Forte Biosciences, Inc. to Present at Upcoming Investor Meetings
Forte Biosciences (NASDAQ: FBRX), a clinical-stage biopharmaceutical company specializing in autoimmune and autoimmune-related diseases, has announced its participation in two major investor conferences. CEO Paul Wagner, PhD will deliver presentations at:
1. The Guggenheim SMID Cap Biotech Conference on February 6th at 1:30 PM ET in New York, NY at the Lotte New York Palace
2. The TD Cowen 45th Annual Healthcare Conference on March 3rd at 10:30 AM ET in Boston, MA at the Boston Marriott Copley Place
Forte Biosciences (NASDAQ: FBRX), un'azienda biofarmaceutica in fase clinica specializzata in malattie autoimmuni e correlate, ha annunciato la sua partecipazione a due importanti conferenze per investitori. Il CEO Paul Wagner, PhD presenterà a:
1. La Guggenheim SMID Cap Biotech Conference il 6 febbraio alle 13:30 ET a New York, NY presso il Lotte New York Palace
2. La TD Cowen 45th Annual Healthcare Conference il 3 marzo alle 10:30 ET a Boston, MA presso il Boston Marriott Copley Place
Forte Biosciences (NASDAQ: FBRX), una empresa biofarmacéutica en fase clínica que se especializa en enfermedades autoinmunes y relacionadas, ha anunciado su participación en dos importantes conferencias para inversores. El CEO Paul Wagner, PhD hará presentaciones en:
1. La Guggenheim SMID Cap Biotech Conference el 6 de febrero a la 1:30 PM ET en Nueva York, NY en el Lotte New York Palace
2. La TD Cowen 45th Annual Healthcare Conference el 3 de marzo a las 10:30 AM ET en Boston, MA en el Boston Marriott Copley Place
Forte Biosciences (NASDAQ: FBRX)는 자기 면역 질환 및 관련 질환을 전문으로 하는 임상 단계의 생명공학 회사로, 두 개의 주요 투자자 콘퍼런스에 참여할 것임을 발표했습니다. CEO Paul Wagner, PhD는 다음과 같은 발표를 할 예정입니다:
1. Guggenheim SMID Cap Biotech 회의가 2월 6일 오후 1:30 ET에 뉴욕, NY의 Lotte New York Palace에서 열립니다.
2. TD Cowen 제45회 연례 헬스케어 회의가 3월 3일 오전 10:30 ET에 매사추세츠주 보스턴의 Boston Marriott Copley Place에서 열립니다.
Forte Biosciences (NASDAQ: FBRX), une entreprise biopharmaceutique en phase clinique spécialisée dans les maladies auto-immunes et connexes, a annoncé sa participation à deux grandes conférences pour investisseurs. Le PDG Paul Wagner, PhD fera des présentations lors de :
1. La Guggenheim SMID Cap Biotech Conference le 6 février à 13h30 ET à New York, NY au Lotte New York Palace
2. La TD Cowen 45e Conférence annuelle sur la santé le 3 mars à 10h30 ET à Boston, MA au Boston Marriott Copley Place
Forte Biosciences (NASDAQ: FBRX), ein biopharmazeutisches Unternehmen in der klinischen Phase, das sich auf Autoimmun- und autoimmunbedingte Krankheiten spezialisiert hat, hat seine Teilnahme an zwei bedeutenden Investorenkonferenzen angekündigt. CEO Paul Wagner, PhD wird Präsentationen halten bei:
1. Der Guggenheim SMID Cap Biotech Conference am 6. Februar um 13:30 Uhr ET in New York, NY im Lotte New York Palace
2. Der TD Cowen 45. jährlichen Gesundheitskonferenz am 3. März um 10:30 Uhr ET in Boston, MA im Boston Marriott Copley Place
- None.
- None.
Forte’s CEO, Paul Wagner, PhD will be presenting at the Guggenheim SMID Cap Biotech Conference at 1:30 PM ET on February 6th hosted at the Lotte New York Palace in
Additionally, on March 3rd at 10:30 AM ET, Dr. Wagner will be presenting at the TD Cowen 45th Annual Healthcare Conference hosted at the Boston Marriott Copley Place in
About Forte
Forte Biosciences, Inc. is a clinical-stage biopharmaceutical company that is advancing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications.
Source: Forte Biosciences, Inc.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250203279326/en/
LifeSci Advisors
Mike Moyer, Managing Director
mmoyer@lifesciadvisors.com
Source: Forte Biosciences, Inc.
FAQ
When and where is Forte Biosciences (FBRX) presenting at the Guggenheim SMID Cap Biotech Conference?
When is FBRX presenting at the TD Cowen Healthcare Conference?
Which upcoming investor conferences will Forte Biosciences (FBRX) attend in early 2024?
Who will represent Forte Biosciences (FBRX) at the upcoming investor conferences?
